LCN2 and chronic kidney disease: NGAL is a promising biomarker for acute or chronic kidney disease, where iron binds to NGAL and is enucleated by neutrophil gelatinase-associated lipid calin receptor (NGALR) in distal tubules (Langelueddecke et al., 2012).